U.S. Tobacco Stock News

If you are wondering whether Tronox Holdings is attractively priced or looking stretched, the recent share price moves give some important clues about where value might sit today. The stock last closed at US$9.01, with returns of 22.3% over 7 days, 25.8% over 30 days, 111.0% year to date and 31.8% over 1 year, while the 3 year and 5 year returns sit at 26.8% and 43.3% declines. Recent coverage has focused on how Tronox fits into the wider materials sector and what shifting expectations for...

What Aurinia Pharmaceuticals offers and where it stands today Aurinia Pharmaceuticals (AUPH) focuses on therapies for autoimmune diseases, anchored by its LUPKYNIS treatment for lupus nephritis. The company reported revenue of $283.055 million and net income of $287.202 million in the latest reported period. See our latest analysis for Aurinia Pharmaceuticals. Aurinia’s share price has been volatile in recent months, with a 1-day share price return of 1.60% and 7-day return of 3.77%, while...

In recent weeks, Axon Enterprise has seen strong demand for its AI-powered public safety tools and drones, alongside rising bookings for long-term contracts and mounting anticipation around an upcoming earnings release that analysts expect to show earnings per share growth. An interesting shift is how Axon’s expanding role in AI-driven situational awareness and defense-related applications is tying its growth prospects more closely to government spending priorities and conflict-related...

Viking Therapeutics (NasdaqCM:VKTX) has completed patient enrollment in its Phase 3 VANQUISH-2 trial for VK2735. The trial is evaluating VK2735, a dual GLP-1/GIP agonist, in obesity and type 2 diabetes. This milestone moves VK2735 further along Viking's clinical development path as of 2026. For you as an investor, the VANQUISH-2 enrollment milestone puts fresh attention on Viking Therapeutics, a clinical-stage company focused on metabolic and endocrine diseases. VK2735 sits within the...

Wondering whether SailPoint at US$12.28 is starting to look interesting or still too expensive for the risk you are taking. The stock has been under pressure, with a 0.5% decline over the last 7 days, 6.4% over the last month, and a year to date return of 35.2% and 40.2% over the past year. These moves are occurring as the market continues to reassess software names and focus more closely on business quality, balance sheet strength, and cash generation. For SailPoint, this context matters...

In March 2026, Organic Payment Gateways announced it now provides tested, specialized credit card processing integrations for Farm Bill-compliant US cannabis seed businesses using Wix e-commerce sites, bypassing restrictions from mainstream processors like Wix Payments, Stripe, and PayPal. The integrations pair high-risk-friendly merchant accounts with Authorize.Net and third-party carts while preserving existing Wix store designs, potentially making Wix a more practical option for regulated...

Wondering whether Western Alliance Bancorporation at around US$70 a share looks attractively priced or not? This article breaks down what the current valuation really implies for you as a shareholder or potential investor. The stock has moved 4.2% over the last week, while sitting on a 20.5% decline over 30 days and a 17.9% decline year to date, with an 8.2% decline over the last year and a very large 3 year return of around 2x. These swings have kept Western Alliance in the headlines, with...

Primerica stock snapshot after recent performance Primerica (PRI) has caught investor attention after mixed recent returns, with the stock roughly flat over the past month, a modest gain over the past week, and a negative total return over the past year. See our latest analysis for Primerica. At a share price of $253.69, Primerica has seen short term share price momentum cool, while the 1 year total shareholder return of 11.05% decline contrasts with 3 and 5 year total returns of 56.70% and...

Netflix raised subscription prices across all U.S. plans, including ad supported, standard, and premium tiers. The price change is tied to a broader content push into live events, live sports, video podcasts, and original programming. This is the first broad price adjustment since January 2025 and reflects a shift in how Netflix is approaching monetization and growth. Netflix, NasdaqGS:NFLX, is trading at $93.32, with the share price broadly flat over the past year at a 0.1% decline. Over...

If you are wondering whether American Public Education at about US$57.42 still offers value or has run too far ahead of itself, you are not alone. The stock has posted returns of 5.3% over 7 days, 26.3% over 30 days, 58.8% year to date and 148.2% over 1 year. Over 3 years the gain is around 11x and over 5 years it is 58.2%. Recent coverage around American Public Education has focused on how the business is positioned within the Consumer Services sector and how its model responds to changing...

Parker-Hannifin Corporation recently disclosed that long-serving director Kevin A. Lobo will not stand for reelection at the 2026 Annual Meeting, following his election to the Board of GE HealthCare Technologies, although he will remain on Parker-Hannifin’s Board until his current term ends. This leadership change comes as Parker-Hannifin’s Aerospace Systems segment reports record quarterly revenue and operating margins supported by a multi-billion-dollar backlog, highlighting both...

If you are wondering whether IDEXX Laboratories at around US$573 per share still makes sense for your portfolio, the key question is what you are actually paying for the underlying business. The stock has delivered a 35.7% return over the last year, even as the share price shows a 1.1% decline over 7 days, an 11.7% decline over 30 days, and a 14.4% decline year to date. These shifts can change how investors think about both upside and risk. Recent coverage has focused on IDEXX Laboratories...

Index inclusion puts EMCOR Group (EME) on more investors’ radar EMCOR Group (EME) was added to the FTSE All-World Index in March 2026. This inclusion can attract fresh demand as index funds and institutional investors adjust their holdings. See our latest analysis for EMCOR Group. Despite a recent 1-day share price decline of 5.03% and a 30-day share price decline of 9.98% to US$726.31, EMCOR’s 1-year total shareholder return of 91.87% and 5-year total shareholder return of about 5.5x suggest...

In February 2026, Raymond James upgraded The Baldwin Insurance Group Inc. to a strong Buy rating after the company delivered its sixth consecutive year of leading industry organic growth, margin expansion, and robust adjusted diluted earnings per share. At the same time, Baldwin Insurance Group authorized a US$250,000,000 share repurchase program over the next 12 months, signaling management’s confidence in the business and capital allocation priorities. We’ll now examine how Baldwin...

Q4 Earnings Put Elevance Health (ELV) in Focus Elevance Health (ELV) moved back into the spotlight after reporting fourth quarter and full-year 2025 results, highlighting Medicaid and Medicare Advantage pressures alongside Health Benefits revenue growth and a 2026 adjusted EPS target of at least $25.50. See our latest analysis for Elevance Health. At a share price of US$294.25, Elevance Health has seen a 10.05% 1 month share price decline and a 16.94% year to date share price decline, while...

Dividend decision and what it means for investors Coca-Cola FEMSA. de (NYSE:KOF) shareholders have approved a cash dividend of MXN 0.9675 per share for fiscal 2025, to be paid in four equal installments across April, July, October, and December 2026. Each payment will amount to MXN 0.241875 per share, or MXN 1.935 per KOF UBL unit. This provides investors with clear visibility on expected cash distributions through next year. See our latest analysis for Coca-Cola FEMSA. de. The dividend...

Aflac (NYSE:AFL) has introduced a hybrid term life and long term care rider aimed at aging U.S. consumers. The company is responding to growing long term care needs with a product that blends life insurance coverage and potential long term care benefits. Activist shareholder John Chevedden has filed a proposal urging Aflac to separate the Chairman and CEO roles. Aflac’s board is recommending shareholders vote against the governance proposal at the upcoming annual meeting. Aflac, trading...

Circle Internet Group rapidly reversed a recent decision to blacklist certain USDC wallets after sharp criticism from users and industry participants. The move has raised fresh questions about censorship risk, issuer control over stablecoins, and how far compliance actions can go before trust is affected. Investors and users are watching how Circle refines its approach to regulatory demands while keeping USDC perceived as a reliable settlement asset. Circle Internet Group (NYSE:CRCL) sits...

RBC Capital has initiated coverage of Weatherford International (WFRD) with a positive view, citing peer leading cash generation, strong returns, and what it sees as an attractive valuation during current industry supply disruptions. See our latest analysis for Weatherford International. Weatherford International’s share price has been volatile recently, with a 9.63% 7 day share price return offsetting a 10.22% 30 day share price decline. Its 1 year total shareholder return of 78.30% and very...

Leaked details of Anthropic's upcoming Claude Mythos AI model suggest powerful offensive cyber capabilities focused on security use cases. The leak has sparked concerns that AI driven cyber tools could outpace current defenses and pressure premium security platforms. CrowdStrike Holdings (NasdaqGS:CRWD) shares, recently at $392.62, have been caught in a sector wide selloff as investors reassess AI related cyber risks. For CrowdStrike, the news lands after a mixed stretch for shareholders,...

PayPal Holdings (PYPL) sits at the intersection of fresh regulatory pressure and product expansion, as US regulators question its account practices while the company rolls out its PYUSD stablecoin across 70 markets worldwide. See our latest analysis for PayPal Holdings. The recent mix of regulatory warnings and new product launches has not yet translated into share price strength. A 90 day share price return of 24.63% decline and a 1 year total shareholder return of 34.01% decline point to...

Recently, CF Industries Holdings was removed from the FTSE All-World Index and urged shareholders to vote against a proposal limiting large executive severance packages at its upcoming April 28, 2026 annual meeting. Together with an upbeat analyst reassessment tied to tight nitrogen markets, these developments highlight how corporate governance choices intersect with CF Industries’ positioning in global fertilizer and low-carbon ammonia markets. We’ll now examine how CF Industries’ index...

If you are wondering whether West Pharmaceutical Services is priced fairly or carrying a premium, the recent share performance gives an important starting clue before looking at the numbers behind it. The stock last closed at US$248.12, with returns of 3.2% over 7 days, 1.1% over 30 days, a 10.2% decline year to date, and a 10.1% gain over 1 year. This combination paints a mixed picture of recent sentiment. Recent coverage on West Pharmaceutical Services has focused on its role in...

Without a specific news announcement driving attention today, MSC Industrial Direct (MSM) still gives investors a lot to consider, including its US$3.8b in revenue and its recent mixed share price moves. See our latest analysis for MSC Industrial Direct. The recent 1-day share price decline of 2.63% to US$89.48 follows a 7-day gain of 2.99% and a 1-year total shareholder return of 15.93%, pointing to steady long-term momentum despite some near-term volatility. If this kind of industrial...